• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: CHRISTOPH MIETHKE GMBH & CO KG M.BLUE 5 SYS W.PED.CONTROL RESERVOIR; HYDROCEPHALUS MANAGEMENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

CHRISTOPH MIETHKE GMBH & CO KG M.BLUE 5 SYS W.PED.CONTROL RESERVOIR; HYDROCEPHALUS MANAGEMENT Back to Search Results
Model Number FX816T
Medical Device Problem Code Mechanical Problem (1384)
Health Effect - Clinical Code Hydrocephalus (3272)
Date of Event 07/11/2022
Type of Reportable Event Serious Injury
Event or Problem Description
It was reported that a m.Blue (part # fx816t) was implanted during a procedure performed on an unknown date.According to the complainant, the valve was believed to be not adjustable.The patient will be reviewed again in six (6) weeks.At this review, the surgeon will decide whether the product should be explanted or not.
 
Additional Manufacturer Narrative
Manufacturing site evaluation: the valve is still implanted and an investigation could not be performed.Should relevant additional information / investigation results become available, a supplemental medwatch report will be submitted.
 
Additional Manufacturer Narrative
Manufacturing and quality control data: the m.Blue® was manufactured by a qualified employee in december 2020.Deviations during assembly did not occur.The valve was sterilized by miethke and released for shipment after final inspection.The m.Blue® has a fixed/ normal pressure range of 5 to 45 cmh2o.The valve was inspected as article fx816t.All parameters have been inspected and approved during the manufacturing process.All parameters have been assessed as meeting specifications.Visual inspection: no significant deformations or damage of the valve were detected during the visual inspection.Permeability test: a permeability test has shown that the valve is permeable.Adjustment test: the m.Blue® valve was tested and is not adjustable throughout the normal range.Braking force and brake function test: the brake functionality test has shown that the brake function is operational, however the braking force cannot be measured due to the non-adjustability of the valve.(see section 2.6).Computer controlled test: to investigate the claim of over-drainage, the opening pressure is measured using a miethke computer controlled testing apparatus which simulates a cerebrospinal fluid flow.The results show that the valve is not operating within the acceptable tolerance in the horizontal and vertical position.Internal inspection: after dismantling of the valve, deposits were found in m.Blue®.Results: based on the results of our investigation, we were able to determine at the time of our investigation an accelerated outflow and adjustment difficulties at the valve.The identified deposits can be named as the cause for the functional deviations.We can exclude a defect at the time of release.The valve met all specifications of the final inspection when released from christoph miethke gmbh & co.Kg.No further regulatory actions are required from our point of view.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
M.BLUE 5 SYS W.PED.CONTROL RESERVOIR
Common Device Name
HYDROCEPHALUS MANAGEMENT
Manufacturer (Section D)
CHRISTOPH MIETHKE GMBH & CO KG
ulanenweg 2
potsdam, 14469
GM  14469
Manufacturer (Section G)
CHRISTOPH MIETHKE GMBH & CO KG
ulanenweg 2
potsdam, 14469
GM   14469
Manufacturer Contact
joerg knebel
ulanenweg 2
potsdam, 14469
GM   14469
MDR Report Key15204404
Report Number3004721439-2022-00231
Device Sequence Number14615522
Product Code JXG
UDI-Device Identifier04041906504526
UDI-Public4041906504526
Combination Product (Y/N)N
Initial Reporter CountrySZ
PMA/510(K) Number
K192266
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2021
Device Explanted Year2022
Serviced by Third Party (Y/N)Unknown
Reporter Type Manufacturer
Report Source Other,Foreign,User Facility,Company Representative
Initial Reporter Occupation Physician
Type of Report Initial,Followup
Report Date (Section B) 10/05/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Expiration Date12/07/2025
Device Model NumberFX816T
Device Catalogue NumberFX816T
Device Lot Number20050890
Was Device Available for Evaluation? Device Returned to Manufacturer
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 07/11/2022
Supplement Date Received by Manufacturer09/07/2022
Initial Report FDA Received Date08/10/2022
Supplement Report FDA Received Date10/05/2022
Was Device Evaluated by Manufacturer? (Y/N) Yes
Date Device Manufactured12/11/2020
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Outcome Attributed to Adverse Event Required Intervention;
Patient SexMale
-
-